김하경 교수의 진료시간표

김하경 교수의 상세정보

• 2004 .03 .01 ~  2007 .08 .31 :  이화여자대학교 학사
• 2009 .03 .01 ~  2013 .02 .28 :  이화여자대학교 석사
• 2015 .03 .01 ~  2020 .08 .31 :  성균관대학교 박사

• 2013 .03 .01 ~  2014 .02 .28 :  삼성서울병원 인턴
• 2014 .03 .01 ~  2018 .02 .28 :  삼성서울병원 방사선종양학과 레지던트
• 2018 .03 .01 ~  2019 .02 .28 :  삼성서울병원 방사선종양학과 전임의
• 2019 .03 .01 ~  2020 .02 .28 :  고려대학교구로병원 방사선종양학과 전임의
• 2020 .03 .01 ~   :  고려대학교구로병원 방사선종양학과 임상교원

• 2014 .03 .01 ~   :  대한방사선종양학회 정회원
• 2018 .09 .01 ~   :  대한폐암학회 정회원
• 2018 .09 .01 ~   :  세계폐암학회(IASLC) 정회원
• 2019 .03 .01 ~   :  유럽종양학회(ESMO) 정회원

• 2022 .09 .01 ~   :  한국연구재단 중견연구 과제 연구책임자

• 2016 .08 .29 ~  2016 .09 .11 :  미국 Mayo Clinic 방사선종양학과 연수
• 2016 .09 .12 ~  2016 .09 .23 :  미국 Massachusetts General Hospital 방사선종양학과 연수
• 2016 .09 .24 ~  2016 .09 .28 :  미국 방사선종양학회 구연발표
• 2019 .04 .10 ~  2019 .04 .13 :  유럽 폐암학회 구연발표
• 2019 .12 .06 ~  2019 .12 .08 :  일본 폐암학회 구연발표
• 2020 .11 .19 ~  2020 .11 .20 :  유럽 종양학회 포스터발표

• [국내논문] (Can we omit prophylactic inguinal nodal irradiation in anal cancer patients?)
• [SCI] (Do New pN Subclassifications Proposed by IASLC’s Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?)
• [SCI] (Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy)
• [SCI] (Leptomeningeal enhancement on preoperative brain MRI in patients with glioblastoma and its clinical impact)
• [국외논문] (Sigmoid colon perforation after postoperative hypofractionated intensity-modulated radiation therapy in a cervical cancer patient)
• [SCI] (Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion)
• [SCI] (The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans)
• [SCI] (Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy)
• [SCI] (Impact of underlying pulmonary diseases on treatment outcomes in early-stage non-small cell lung cancer treated with definitive radiotherapy.)
• [SCI] (Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor.)
• [SCI] (Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy)
• [SCI] (Germline BRCA mutation and clinical outcomes in breast cancer patients focusing on survival and failure patterns: A long-term follow-up study of Koreans)
• [SCI] (Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer.)
• [SCI] (Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: Should they clash or reconcile?)
• [SCI] (Clinical Outcomes of Stereotactic Ablative Radiotherapy for All Stages of Non-Small Cell Lung Cancer; Definitive Versus Consolidative)
• [SCI] (Consolidative high-dose thoracic radiotherapy for limited metastatic nonsmall cell lung cancer: Focusing on oligo-progressive disease)

최종수정일 : 2023.05.08